Patients with Coronavirus-associated disease-2019 (COVID-19) display alterations of the hemostatic system and the presence of a prothrombotic status frequently leading to vascular complications. However, the impact of COVID-19 on platelet activity, aggregation and agglutination still needs to be clarified. We measured total levels of von Willebrand factor (vWF) and vWF binding to the platelet glycoprotein (Gp) complex (GPIb-IX-V), in a cohort of COVID-19 patients admitted to the intensive care unit of our Institution. Moreover, we evaluated platelet aggregation in response to agonists (ADP, collagen, arachidonic acid) and platelet agglutination in response to ristocetin. We found that levels of vWF antigen and the active form of vWF binding to platelets (vWF:RCo), were markedly increased in these patients. These results were associated with higher agglutination rates induced by ristocetin, thereby indirectly indicating an increased capability of vWF to bind to platelets. Conversely, we found that platelet aggregation in response to both ADP and collagen was lower in COVID-19 patients compared to healthy volunteers. This study shows that COVID-19 is associated with increased vWF-induced platelet agglutination but reduced platelet responsivity to aggregation stimuli. Our findings have translational relevance since platelet adhesion to vWF may represent a marker to predict possible complications and better delineate therapeutic strategies in COVID-19 patients.

Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? / Ruberto, F.; Chistolini, A.; Curreli, M.; Frati, G.; Marullo, A. G. M.; Biondi-Zoccai, G.; Mancone, M.; Sciarretta, S.; Miraldi, F.; Alessandri, F.; Ceccarelli, G.; Barone, F.; Santoro, C.; Alvaro, D.; Pugliese, F.; Pulcinelli, F. M.; Albante, A.; Antonelli, G.; Araimo-Morselli, F.; Auricchio, D.; Bilotta, F.; Brisciani, G. B. -Z. M.; Bruno, K.; Cappannoli, A.; Cardinale, V.; Celli, P.; Consolo, S.; Croce, C.; Crocitti, B.; D'Ettorre, G.; De Daniela, L.; De Lazzaro, F.; Fedele, F.; Galardo, G.; Giannetti, L.; Ianni, S.; Imperiale, C.; Maestrini, V.; Magnanimi, E.; Maldarelli, F.; Martelli, S.; Mastroianni, C.; Messina, T.; Pattelli, E.; Pecorari, F.; Perrella, S.; Piazzolla, M.; Portieri, M.; Pulcinelli, F. M.; Ratini, F.; Ricci, C.; Santopietro, Pietro; Tellan, G.; Titi, L.; Tordiglione, P.; Tosi, A.; Trigilia, F.. - In: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. - ISSN 0929-5305. - (2021). [10.1007/s11239-020-02339-6]

Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?

Ruberto F.;Chistolini A.;Frati G.;Marullo A. G. M.;Biondi-Zoccai G.;Mancone M.;Sciarretta S.;Miraldi F.;Alessandri F.;Ceccarelli G.;Alvaro D.;Pugliese F.;Pulcinelli F. M.;Albante A.;Antonelli G.;Bilotta F.;Cappannoli A.;Cardinale V.;Celli P.;Crocitti B.;D'Ettorre G.;De Lazzaro F.;Galardo G.;Ianni S.;Maestrini V.;Magnanimi E.;Maldarelli F.;Mastroianni C.;Pattelli E.;Pecorari F.;Piazzolla M.;Ratini F.;Santopietro P.;Tellan G.;Titi L.;Trigilia F.
2021

Abstract

Patients with Coronavirus-associated disease-2019 (COVID-19) display alterations of the hemostatic system and the presence of a prothrombotic status frequently leading to vascular complications. However, the impact of COVID-19 on platelet activity, aggregation and agglutination still needs to be clarified. We measured total levels of von Willebrand factor (vWF) and vWF binding to the platelet glycoprotein (Gp) complex (GPIb-IX-V), in a cohort of COVID-19 patients admitted to the intensive care unit of our Institution. Moreover, we evaluated platelet aggregation in response to agonists (ADP, collagen, arachidonic acid) and platelet agglutination in response to ristocetin. We found that levels of vWF antigen and the active form of vWF binding to platelets (vWF:RCo), were markedly increased in these patients. These results were associated with higher agglutination rates induced by ristocetin, thereby indirectly indicating an increased capability of vWF to bind to platelets. Conversely, we found that platelet aggregation in response to both ADP and collagen was lower in COVID-19 patients compared to healthy volunteers. This study shows that COVID-19 is associated with increased vWF-induced platelet agglutination but reduced platelet responsivity to aggregation stimuli. Our findings have translational relevance since platelet adhesion to vWF may represent a marker to predict possible complications and better delineate therapeutic strategies in COVID-19 patients.
File allegati a questo prodotto
File Dimensione Formato  
Ruberto_Von-Willebrand-factor_2021.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 808.54 kB
Formato Adobe PDF
808.54 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1513071
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 11
social impact